Greenberg Traurig Maher (GTM) and Willkie Farr & Gallagher have taken roles on AstraZeneca's $1.15bn (£740m) acquisition of US pharma company Pearl Therapeutics. AstraZeneca - the UK's second-largest drugs company - will acquire 100% of Pearl's shares for $560m (£361m) cash, with further funds of $450m (£290m) and $140m (£90m) payable if certain regulatory and sales-related milestones are reached.
June 10, 2013 at 07:54 AM
1 minute read
The original version of this story was published on Legalweek
Greenberg Traurig Maher (GTM) and Willkie Farr & Gallagher have taken roles on AstraZeneca’s $1.15bn (£740m) acquisition of US pharma company Pearl Therapeutics.
AstraZeneca – the UK’s second-largest drugs company – will acquire 100% of Pearl’s shares for $560m (£361m) cash, with further funds of $450m (£290m) and $140m (£90m) payable if certain regulatory and sales-related milestones are reached.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
